Konvencionalni i biološki bolest-modificirajući lijekovi i kardiovaskularni rizik Conventional and biological disease- modifying antirheumatic drugs and cardiovascular riskAuthors:Tatjana Zekić Summary Sažetak Vol.: 2025;72(Supl 1/Suppl 1) https://doi.org/10.33004/reumatizam-supp-71-1-11 Tatjana Zekić Preuzmi PDF Draženka Kontek2025-11-12T11:45:17+01:00 Podijeli članak FacebookXLinkedInWhatsAppEmail:
